Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective

Werner Scherbaum, Gordon Goodall, Katrina Erny-Albrecht, Massimo Massi-Benedetti, Erland Erdmann, William Valentine

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	1-12
Number of pages	12
Journal	Cost Effectiveness and Resource Allocation
Volume	7
Issue number	9
Publication status	Published - 2009

Cite this

@article{4b976ff9677e4037a8a7cea6a6f674a2,

title = "Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective",

author = "Werner Scherbaum and Gordon Goodall and Katrina Erny-Albrecht and Massimo Massi-Benedetti and Erland Erdmann and William Valentine",

year = "2009",

language = "English",

volume = "7",

pages = "1--12",

journal = "Cost Effectiveness and Resource Allocation",

issn = "1478-7547",

publisher = "Springer ",

number = "9",

}

TY - JOUR

T1 - Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective

AU - Scherbaum, Werner

AU - Goodall, Gordon

AU - Erny-Albrecht, Katrina

AU - Massi-Benedetti, Massimo

AU - Erdmann, Erland

AU - Valentine, William

PY - 2009

Y1 - 2009

M3 - Article

SN - 1478-7547

VL - 7

SP - 1

EP - 12

JO - Cost Effectiveness and Resource Allocation

JF - Cost Effectiveness and Resource Allocation

IS - 9

ER -